The Nordic life sciences sector—renowned for its innovation and resilience—faces a distinct set of challenges in today’s volatile market. Mid-cap med-tech and medical device companies, in particular, are navigating a complex landscape shaped by global market fluctuations, regulatory changes, and shifting investor sentiment. The central question for boards and leadership teams is whether to embrace risk or adopt a more cautious "wait-and-see" strategy.
Read MoreWhat is the business potential in some of the new tendencies within executive search and how can organisations make the most of a broader pool of C-suite and board level candidates? An increasingly international approach to organisational structure and executive search provides great opportunities to level-up leadership capabilities, enabling us to look for leadership in a much broader scope.
Read MoreIn this article Jill Lockett, Strategic Advisor at Alumni Global discusses the issues of resilience within sustainable leadership and how we best support leaders within Life Sciences in today’s turbulent business climate and going forward. Looking at resilience through two different perspectives we have listened to individuals in our network and across our own business community, about the models of joint working and partnership that have actively supported sustainable leadership and built resilience in their teams.
Read More
